• Info
  • Insider Ownership

Insider Trading & Ownership of FOREST BASKETT

Location
Menlo Park, CA
Summary
The estimated net worth of FOREST BASKETT is at least $394,599,594 dollars as of 06 Oct 2025. FOREST BASKETT is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146,153,662. FOREST BASKETT is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $108,897,125. FOREST BASKETT is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61,084,408. FOREST BASKETT is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38,638,855. FOREST BASKETT is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $21,051,285. FOREST BASKETT is the 10%+ Owner of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $14,998,764. FOREST BASKETT is the 10%+ Owner of Coursera, Inc. and owns shares of Coursera, Inc. (COUR) stock worth about $1,846,623. FOREST BASKETT is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1,204,731. FOREST BASKETT is the Director of Robinhood Markets, Inc. and owns shares of Robinhood Markets, Inc. (HOOD) stock worth about $450,661. FOREST BASKETT is the 10%+ Owner of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $125,856. FOREST BASKETT is the 10%+ Owner of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $48,300. FOREST BASKETT is the 10%+ Owner of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $46,330. FOREST BASKETT is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $43,398. FOREST BASKETT is the 10%+ Owner of Desktop Metal, Inc. and owns shares of Desktop Metal, Inc. (DM) stock worth about $5,377. FOREST BASKETT is the 10%+ Owner of Eargo, Inc. and owns shares of Eargo, Inc. stock worth about $4,219.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when FOREST BASKETT files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of FOREST BASKETT

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146,153,662 28 Jun 2021
SVRA Savara Inc 10%+ Owner $108,897,125 17 Jul 2023
KRRO Korro Bio, Inc. 10%+ Owner $61,084,408 22 Apr 2024
MBX MBX Biosciences, Inc. 10%+ Owner $38,638,855 16 Sep 2024
TRVI Trevi Therapeutics, Inc. 10%+ Owner $21,051,285 11 Apr 2022
ARDX ARDELYX, INC. 10%+ Owner $14,998,764 09 Dec 2021
COUR Coursera, Inc. 10%+ Owner $1,846,623 15 Feb 2023
MTCR Metacrine, Inc. 10%+ Owner $1,204,731 10 Dec 2021
HOOD Robinhood Markets, Inc. Director $450,661 02 May 2022
IONQ, IONQ-WT IonQ, Inc. 10%+ Owner $125,856 16 Nov 2022
AVEO AVEO PHARMACEUTICALS, INC. 10%+ Owner $48,300 19 Oct 2022
SGMT Sagimet Biosciences Inc. 10%+ Owner $46,330 29 Jan 2024
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $43,398 13 Jun 2023
DM Desktop Metal, Inc. 10%+ Owner $5,377 08 Jun 2021
EAR Eargo, Inc. 10%+ Owner $4,219 24 May 2021
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$5,670 -100% 02 Oct 2025
AKUS Akouos, Inc. 10%+ Owner 30 Nov 2022
ACLX Arcellx, Inc. 10%+ Owner 20 Dec 2022
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner 24 May 2022

Insider Transactions Reported by FOREST BASKETT:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.